Chemical Compound Review:
Mistalin 2-[[1-[1-[(4-fluorophenyl) methyl]benzoimid...
Synonyms:
Mizollen, Zolistam, Zolistan, Mistamine, Mizolen, ...
- Anaphylaxis to mizolastine. Weidinger, S., Mempel, M., Ollert, M., Elser, I., Rakoski, J., Köhn, F.M., Ring, J. J. Allergy Clin. Immunol. (2004)
- Clinical pharmacokinetics of mizolastine. Lebrun-Vignes, B., Diquet, B., Chosidow, O. Clinical pharmacokinetics. (2001)
- Lack of behavioural toxicity of mizolastine: a review of the clinical pharmacology studies. Rosenzweig, P., Patat, A. Clin. Exp. Allergy (1999)
- Inhibition of HERG1 K(+) channels by the novel second-generation antihistamine mizolastine. Taglialatela, M., Pannaccione, A., Castaldo, P., Giorgio, G., Annunziato, L. Br. J. Pharmacol. (2000)
- Mizolastine in primary acquired cold urticaria. Dubertret, L., Pecquet, C., Murrieta-Aguttes, M., Leynadier, F. J. Am. Acad. Dermatol. (2003)
- Effects of mizolastine, a new antihistamine, on psychomotor performance and memory in elderly subjects. Patat, A., Gram, L.F., Dubruc, C., Brohier, S., Cabanis, M.J., Rosenzweig, P. International clinical psychopharmacology. (1994)
- Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadine. Frèche, C., Leynadier, F., Horak, F., Hide, D., Gracia, F.D., Goos, M., Bachert, C., Horvath, A., Antosova, E., Verrecchia, M., Soussen, P.B. Ann. Allergy Asthma Immunol. (2002)
- UV erythema reducing capacity of mizolastine compared to acetylsalicylic acid or both combined in comparison to indomethacin. Grundmann, J.U., Böckelmann, R., Bonnekoh, B., Gollnick, H.P. Photochem. Photobiol. (2001)
- Urticaria to cetirizine. Tella, R., Gaig, P., Bartra, J., Garcia-Ortega, P. Journal of investigational allergology & clinical immunology : official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunología. (2002)
- Clinical advantages of dual activity in urticaria. Kontou-Fili, K. Allergy (2000)
- Population pharmacokinetic analysis of mizolastine and validation from sparse data on patients using the nonparametric maximum likelihood method. Mesnil, F., Mentré, F., Dubruc, C., Thénot, J.P., Mallet, A. Journal of pharmacokinetics and biopharmaceutics. (1998)
- Influence of mizolastine on antigen-induced activation of signalling pathways in murine mast cells. Xia, Q., Zhou, W.M., Yang, S., Zhang, S.Q., Chen, B., Wang, D.B., Wang, Y., Zhang, X.J. Clin. Exp. Dermatol. (2006)
- Differential modulation of mediator release from human basophils and mast cells by mizolastine. Triggiani, M., Giannattasio, G., Balestrieri, B., Granata, F., Gelb, M.H., de Paulis, A., Marone, G. Clin. Exp. Allergy (2004)
- Inhibitory effects of mizolastine on ultraviolet B-induced leukotriene B4 production and 5-lipoxygenase expression in normal human dermal fibroblasts in vitro. Yan, Y., Wang, B., Zuo, Y.G., Qu, T. Photochem. Photobiol. (2006)
- Effects of mizolastine in vitro on human immunocompetent and airway cells: evidence for safety and additional property. Oddera, S., Cagnoni, F., Dellacasa, P., Canonica, G.W. Int. Arch. Allergy Immunol. (2000)
- Comparison of the efficacy, safety, and onset of action of mizolastine, cetirizine, and placebo in the management of seasonal allergic rhinoconjunctivitis. MIZOCET Study Group. Sabbah, A., Daele, J., Wade, A.G., Ben-Soussen, P., Attali, P. Ann. Allergy Asthma Immunol. (1999)
- Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans. Molimard, M., Diquet, B., Benedetti, M.S. Fundamental & clinical pharmacology. (2004)
- Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model. Deschamps, C., Dubruc, C., Mentre, F., Rosenzweig, P. Clin. Pharmacol. Ther. (2000)
- The current cardiac safety situation with antihistamines. Yap, Y.G., Camm, A.J. Clin. Exp. Allergy (1999)
- Antihistamines in urticaria. Ring, J., Brockow, K., Ollert, M., Engst, R. Clin. Exp. Allergy (1999)
- QT interval monitoring during clinical studies with mizolastine, a new H1 antihistamine. Delauche-Cavallier, M.C., Chaufour, S., Guérault, E., Lacroux, A., Murrieta, M., Wajman, A. Clin. Exp. Allergy (1999)